The medical and socioeconomic burden of heart failure: A comparative delineation with cancer

International Journal of Cardiology

Volumn 203, Issue , 2016, Pages 279-281

  Farmakis, Dimitrios ^a   Stafylas, Panagiotis ^b   Giamouzis, Gregory ^c   Maniadakis, Nikolaos ^d   Parissis, John ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b Medical Research and Innovation LP   (Greece)

^c UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^d NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

Author keywords

Cancer; Cardiovascular disease; Cost; Epidemiology; Healthcare; Heart failure

Indexed keywords

CANCER MORTALITY; CANCER PROGNOSIS; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; COMPARATIVE STUDY; DISEASE ASSOCIATION; HEALTH CARE COST; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; NEOPLASM; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SOCIOECONOMICS; SYNDROME DELINEATION; AGED; COST OF ILLNESS; ECONOMICS; EUROPEAN UNION; FEMALE; HEALTH CARE DELIVERY; HOSPITALIZATION; INCIDENCE; MALE; NEOPLASMS; PREVALENCE; PROTOCOL COMPLIANCE; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; COST OF ILLNESS; DELIVERY OF HEALTH CARE; EUROPEAN UNION; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; NEOPLASMS; PREVALENCE; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84952690442     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.10.172     Document Type: Editorial

References (28)

1. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, M.J. Blaha A.H.A.S. Committee, and S.S. Subcommittee Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
2. D. Farmakis, J. Parissis, and G. Filippatos Insights into onco-cardiology: atrial fibrillation in cancer J. Am. Coll. Cardiol. 63 2014 945 953
3. Y. Ning, Q. Shen, K. Herrick, R. Mikkelsen, M. Anscher, R. Houlihan, and et al. Cancer Res. 72 8 Suppl 2012 LB-339
4. American Cancer Society Cancer facts & figs Atlanta Am. Cancer Soc. 2015 2015
5. R. Luengo-Fernandez, J. Leal, A. Gray, and R. Sullivan Economic burden of cancer across the: a population-based cost analysis Lancet Oncol. 14 2013 1165 1174
6. N. Howlader, A.M. Noone, M. Krapcho, J. Garshell, D. Miller, S.F. Altekruse, and et al. SEER Cancer Statistics Review, 1975-2012 2015 National Cancer Institute Bethesda, MD http://seer.cancer.gov/csr/1975-2012/ (accessed on July 3
7. American Cancer Society Cancer facts & figs Atlanta Am. Cancer Soc. 2013 2013
8. Agency for Healthcare Research and Quality, Rockville, MD http://www.ahrq.gov (accessed on July 3 2015
9. Statistical Brief #125: Cancer Hospitalizations for Adults Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample; 2012 2009
10. D. Mozaffarian, E.J. Benjamin, A.S. Go, D.K. Arnett, M.J. Blaha, M. Cushman, and et al. Heart disease and stroke statistics - 2015 update: a report from the American Heart Association Circulation 131 2015 e29 322
11. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, K. Dickstein, and et al. ESC Committee for practice guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur. Heart J. 33 2012 1787 1847
12. M. Nichols, N. Townsend, R. Luengo-Fernandez, J. Leal, A. Gray, P. Scarborough, and et al. European Cardiovascular Disease Statistics 2012 2012 European Heart Network Brussels, European Society of Cardiology, Sophia Antipolis
13. D. Farmakis, J. Parissis, and G. Filippatos Acute heart failure: epidemiology, classification, and pathophysiology M. Tubaro, P. Vranckx, S. Price, C. Vrints, The ESC Textbook of Intensive and Acute Cardiac Care 2nd ed. 2015 Oxford University Press
14. D. Farmakis, J. Parissis, J. Lekakis, and G. Filippatos Acute heart failure: epidemiology, risk factors, and prevention Rev. Esp. Cardiol. 68 2015 245 248
15. H. Bueno, J.S. Ross, Y. Wang, J. Chen, M.T. Vidán, S.L. Normand, and et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006 JAMA 303 2010 2141 2147
16. S. Stewart, K. MacIntyre, D.J. Hole, S. Capewell, and J.J. McMurray More 'malignant' than cancer? Five-year survival following a first admission for heart failure Eur. J. Heart Fail. 3 2001 315 322
17. R.D. Kociol, B.G. Hammill, G.C. Fonarow, W. Klaskala, R.M. Mills, A.F. Hernandez, and et al. Generalizability and longitudinal outcomes of a national heart failure clinical registry: comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries Am. Heart J. 160 2010 885 892
18. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, T.M. Brown A.H.A.S. Committee, and S.S. Subcommittee Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
19. S. Stewart, A. Jenkins, S. Buchan, A. McGuire, S. Capewell, and J.J. McMurray The current cost of heart failure to the National Health Service in the UK Eur. J. Heart Fail. 4 2002 361 371
20. J. Parissis, K. Athanasakis, D. Farmakis, N. Boubouchairopoulou, C. Mareti, V. Bistola, and et al. Determinants of the direct cost of heart failure hospitalization in a public tertiary hospital Int. J. Cardiol. 180 2015 46 49
21. C.W. Yancy, M. Jessup, B. Bozkurt, J. Butler, D.E. Casey Jr., M.H. Drazner, and et al. American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 128 2013 e240 e327
22. G.C. Fonarow, N.M. Albert, A.B. Curtis, M. Gheorghiade, Y. Liu, M.R. Mehra, and et al. Incremental reduction in risk of death associated with use of guideline-recommended therapies in patients with heart failure: a nested case-control analysis of IMPROVE HF J. Am. Heart Assoc. 1 2012 16 26
23. M. Komajda, P. Lapuerta, N. Hermans, J.R. Gonzalez-Juanatey, D.J. van Veldhuisen, E. Erdmann, and et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey Eur. Heart J. 26 2005 1653 1659
24. A.P. Maggioni, S.D. Anker, U. Dahlström, G. Filippatos, P. Ponikowski, F. Zannad, and et al. Heart Failure Association of the ESC. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry Eur. J. Heart Fail. 15 2013 1173 1184
25. G. Filippatos, D. Farmakis, V. Bistola, A. Karavidas, A. Mebazaa, A.P. Maggioni, and et al. Temporal trends in epidemiology, clinical presentation and management of acute heart failure: results from the Greek cohorts of the Acute Heart Failure Global Registry of Standard Treatment and the European Society of Cardiology - heart failure pilot survey Eur. Heart J. Acute Cardiovasc. Care 2014 (Epub ahead of print)
26. J.J. McMurray, M. Packer, A.S. Desai, J. Gong, M.P. Lefkowitz, A.R. Rizkala, and et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure N. Engl. J. Med. 371 2014 993 1004
27. A.S. Desai, and L.W. Stevenson Rehospitalization for heart failure: predict or prevent? Circulation 126 2012 501 506
28. C.M. O'Connor, A.B. Miller, J.E. Blair, M.A. Konstam, P. Wedge, M.C. Bahit, and et al. Efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) investigators. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program Am. Heart J. 159 2010 841 849